Contrast-Enhanced Ultrasound for the Evaluation of Renal Cell Carcinoma Cryoablation

Trial Profile

Contrast-Enhanced Ultrasound for the Evaluation of Renal Cell Carcinoma Cryoablation

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2016

At a glance

  • Drugs Perflutren (Primary)
  • Indications Renal cell carcinoma
  • Focus Diagnostic use
  • Most Recent Events

    • 17 Aug 2016 Status changed from recruiting to withdrawn prior to enrolment as the trial was terminated by IRB
    • 16 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top